Li Chen
Founder at HUA MEDICINE (SHANGHAI) LTD.
Net worth: 735 503 $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jo Hua Tsao | F | - | 16 years | |
| Lian Yong Chen | M | 62 |
Hua Medicine Technology (Hong Kong) Ltd.
Hua Medicine (Shanghai) Co., Ltd.
 Hua Medicine (Shanghai) Co., Ltd. BiotechnologyHealth Technology Hua Medicine (Shanghai) Co., Ltd. is a Chinese biotechnology company that focuses on the clinical needs of diabetic patients. The private company is based in Shanghai, China. The company has brought together high-end talents and scientific and technological resources to develop the world's first dorzagliatin (hms5552) for the treatment of type 2 diabetes. Hua Medicine has conducted two phase III clinical trials in 2019, targeting type 2 diabetes patients who have failed to treat the disease with other medications. The company plans to expand the advanced concepts of personalized therapy and management of diabetes to achieve effective control of diabetes and metabolic diseases and complications. The company was founded in 2011 by Li Chen, who has been the CEO since then. | 9 years |
| Jiang Min Wei | M | 53 | 8 years | |
| William Keller | M | 75 | 14 years | |
| Chien Cheng Lin | M | 53 | 6 years | |
| Yiu Leung Cheung | M | 64 | 1 years | |
| Teresa Graham | F | - |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | 19 years |
| Jen Lin Shen | M | - | 14 years | |
| Yiu Wa Tsui | M | 74 | 6 years | |
| Robert Nelsen | M | 60 |
Hua Medicine Technology (Hong Kong) Ltd.
| 14 years |
| Yun Long Du | M | - | 7 years | |
| Li Yan Chang | M | - | 14 years | |
| Yi Zhang | M | - | 6 years | |
| Di Ming Lou | M | 61 |
Tongji University
| - |
| Lee Chan Hang | M | - |
Tongji University
| - |
| Qi Jia Liu | F | - | 10 years | |
| Jie Liu | M | 61 |
Tongji University
| 24 years |
| Er Dong Hua | M | - |
Hua Medicine (Shanghai) Co., Ltd.
Hua Medicine (Shanghai) Co., Ltd. BiotechnologyHealth Technology Hua Medicine (Shanghai) Co., Ltd. is a Chinese biotechnology company that focuses on the clinical needs of diabetic patients. The private company is based in Shanghai, China. The company has brought together high-end talents and scientific and technological resources to develop the world's first dorzagliatin (hms5552) for the treatment of type 2 diabetes. Hua Medicine has conducted two phase III clinical trials in 2019, targeting type 2 diabetes patients who have failed to treat the disease with other medications. The company plans to expand the advanced concepts of personalized therapy and management of diabetes to achieve effective control of diabetes and metabolic diseases and complications. The company was founded in 2011 by Li Chen, who has been the CEO since then. | - |
| Xi Chan Zhu | M | 62 |
Tongji University
| - |
| Da Jian Zhu | M | 70 |
Tongji University
| - |
| Tong Zhang | M | 64 |
Tongji University
| 13 years |
| Yi Ru Huang | M | 61 |
Tongji University
| - |
| Guo Tong Xu | M | 67 |
Tongji University
| 16 years |
| Xu Wen Xiao | M | 71 |
Tongji University
| - |
| Hong Wei Tan | M | 64 |
Tongji University
| - |
| De Wei Chen | M | 67 |
Tongji University
| 38 years |
| Wei Guo Zhou | M | 63 |
Tongji University
| - |
| Fuxing Tang | M | 57 | 4 years | |
| Selina Chu | F | - | - | |
| Xudong Zhao | M | - |
Tongji University
| 20 years |
| Xiaofeng Ma | M | 48 |
Tongji University
| 12 years |
| Wenjie Xu | F | 52 | 6 years | |
| Liang Wu | M | 54 |
Tongji University
| - |
| Xiao Hu Dai | M | 61 |
Tongji University
| 14 years |
| Di Hong | M | 45 | 3 years | |
| Jing Jing Xu | F | - |
Hua Medicine (Shanghai) Co., Ltd.
Hua Medicine (Shanghai) Co., Ltd. BiotechnologyHealth Technology Hua Medicine (Shanghai) Co., Ltd. is a Chinese biotechnology company that focuses on the clinical needs of diabetic patients. The private company is based in Shanghai, China. The company has brought together high-end talents and scientific and technological resources to develop the world's first dorzagliatin (hms5552) for the treatment of type 2 diabetes. Hua Medicine has conducted two phase III clinical trials in 2019, targeting type 2 diabetes patients who have failed to treat the disease with other medications. The company plans to expand the advanced concepts of personalized therapy and management of diabetes to achieve effective control of diabetes and metabolic diseases and complications. The company was founded in 2011 by Li Chen, who has been the CEO since then. | - |
| Fang Xin Li | M | 32 | 1 years | |
| Jia Zhen Huo | M | 62 |
Tongji University
| - |
| Zhen Hua Zhang | M | 82 |
Tongji University
| - |
| Xiao Ping Ye | M | 61 | 14 years | |
| Ling Xia | M | 51 |
Tongji University
| - |
| Gérard Mestrallet | M | 75 |
Tongji University
| - |
| Chang Le Liu | M | 73 |
Tongji University
| - |
| Xin Jun Liang | M | 56 |
Tongji University
| - |
| Wan Gang | M | - |
Tongji University
| - |
| Jochem Peter Heizmann | M | 72 |
Tongji University
| 20 years |
| Dongyuan Yang | M | 70 |
Tongji University
| 22 years |
| Guo Xiang Cheng | M | - |
Tongji University
| - |
| Fang Zheng Chen | M | 76 |
Tongji University
| 28 years |
| Wen Quan Tao | M | 85 |
Tongji University
| - |
| Wei Xing Shi | M | 62 |
Tongji University
| - |
| Hua Ting Zhang | M | 78 |
Tongji University
| - |
| Jian Xin You | M | 63 |
Tongji University
| 40 years |
| Chong Qing Guo | M | 90 |
Tongji University
| - |
| Liguang Li | M | 61 |
Tongji University
| - |
| Wing Yan Yuen | F | 53 | 5 years | |
| Li Shang | M | 51 |
Tongji University
| - |
| Zhuo Ping Yu | M | 64 |
Tongji University
| 39 years |
| Gang Pei | M | 70 |
Tongji University
| - |
| Song Chen | M | 60 |
Tongji University
| - |
| Chun Yan Liu | M | 57 |
Tongji University
| - |
| Si Zong Wu | M | 72 |
Tongji University
| 27 years |
| Tu Cheng Tian | M | 66 |
Zhengzhou University
| 42 years |
| Chun Rong Liao | M | 60 |
Tongji University
| - |
| Shui Li Yu | M | 62 |
Tongji University
| 14 years |
| Qing Xu | M | 60 |
Tongji University
| - |
| Xing Hui Lei | M | 61 |
Tongji University
| - |
| Michael Knierim | M | - |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | - |
| Guo Qiang Li | M | 61 |
Tongji University
| 31 years |
| Chao Kui Qin | M | 55 |
Tongji University
| - |
| Lauren Abrey | F | - |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | - |
| Li Changhong | M | 55 | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hsin Lee | M | - | 6 years | |
| Sheau Yuen Ng | F | 50 |
Iowa State University
| 5 years |
| Pei Qing Tian | M | 62 |
East China Normal University
| 4 years |
| John J. Baldwin | M | 89 | - | |
| Tai Feng Xie | M | 66 |
Zhengzhou University
| 21 years |
| Jun Ling Liu | M | 59 | - | |
| Ge Li | M | 56 | - | |
| Teh Ming Kwauk | M | 71 | 4 years | |
| Yih Pyng Ng | M | 52 |
Iowa State University
| 5 years |
| Thomas L. Gustafson | M | 52 |
Iowa State University
| 4 years |
| Eric H. Chadwick | M | - |
Iowa State University
| 4 years |
| Alan Williams | M | - |
Iowa State University
| 5 years |
| Michael Miller | M | - |
Iowa State University
| 4 years |
| Eric Ritland | M | - |
Iowa State University
| 4 years |
| Mark Nevenhoven | M | - |
Iowa State University
| 4 years |
| Bruce Lehrman | M | - |
Iowa State University
| 2 years |
| Jeff Peter | M | - |
Iowa State University
| 4 years |
| Daren Clark Heitman | M | - |
Iowa State University
| 4 years |
| Christopher L. Arnold | M | - |
Iowa State University
| 4 years |
| Matthew S. Shafer | M | - |
Iowa State University
| 4 years |
| Scott W. Stangeland | M | - |
Iowa State University
| 4 years |
| David J. Slump | M | 55 |
Iowa State University
| 4 years |
| Arief Budiman | M | - |
Iowa State University
| 4 years |
| Julie A. White | F | - |
Iowa State University
| 4 years |
| Donald McEntaffer | M | - |
Iowa State University
| 4 years |
| Mark Boggess | M | 64 |
Iowa State University
| 3 years |
| Erik D. Lassila | M | - |
Iowa State University
| 5 years |
| Spiros Liras | M | - |
Iowa State University
| - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| China | 68 | 68.00% |
| United States | 24 | 24.00% |
| Cayman Islands | 9 | 9.00% |
| Hong Kong | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Li Chen
- Personal Network